4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Hyperoxia Alters Ultrastructure and Induces Apoptosis in Leukemia Cell Lines

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Oxygenation conditions are crucial for growth and tumor progression. Recent data suggests a decrease in cancer cell proliferation occurring after exposure to normobaric hyperoxia. Those changes are associated with fractal dimension. The purpose of this research was to study the impact of hyperoxia on apoptosis and morphology of leukemia cell lines. Two hematopoietic lymphoid cancer cell lines (a T-lymphoblastoid line, JURKAT and a B lymphoid line, CCRF-SB) were tested under conditions of normobaric hyperoxia (FiO 2 > 60%, ± 18h) and compared to a standard group (FiO 2 = 21%). We tested for apoptosis using a caspase-3 assay. Cell morphology was evaluated by cytospin, microphotography after coloration, and analysis by a fractal dimension calculation software. Our results showed that exposure of cell cultures to transient normobaric hyperoxia induced apoptosis (elevated caspase-3) as well as significant and precocious modifications in cell complexity, as highlighted by increased fractal dimensions in both cell lines. These features are associated with changes in structure (pycnotic nucleus and apoptosis) recorded by microscopic analysis. Such morphological alterations could be due to several molecular mechanisms and rearrangements in the cancer cell, leading to cell cycle inhibition and apoptosis as shown by caspase-3 activity. T cells seem less resistant to hyperoxia than B cells.

          Related collections

          Most cited references53

          • Record: found
          • Abstract: found
          • Article: not found

          HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors.

          Solid tumors contain regions of hypoxia, a physiological stress that can activate cell death pathways and, thus, result in the selection of cells resistant to death signals and anticancer therapy. Bcl2/adenovirus EIB 19kD-interacting protein 3 (BNIP3) is a cell death factor that is a member of the Bcl-2 proapoptotic family recently shown to induce necrosis rather than apoptosis. Using cDNA arrays and serial analysis of gene expression, we found that hypoxia induces up-regulation of BNIP3 and its homologue, Nip3-like protein X. Analysis of human carcinoma cell lines showed that they are hypoxically regulated in many tumor types, as well as in endothelial cells and macrophages. Regulation was hypoxia inducible factor-1-dependent, and hypoxia inducible factor-1 expression was suppressed by von Hippel-Lindau protein in normoxic cells. Northern blotting and in situ hybridization analysis has revealed that these factors are highly expressed in human tumors compared with normal tissue and that BNIP3 is up-regulated in perinecrotic regions of the tumor. This study shows that genes regulating cell death can be hypoxically induced and are overexpressed in clinical tumors.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Checking on DNA damage in S phase.

            The precise replication of the genome and the continuous surveillance of its integrity are essential for survival and the avoidance of various diseases. Cells respond to DNA damage by activating a complex network of the so-called checkpoint pathways to delay their cell-cycle progression and repair the defects. In this review we integrate findings on the emerging mechanisms of activation, the signalling pathways and the spatio-temporal organization of the intra-S-phase DNA-damage checkpoint and its impact on the cell-cycle machinery, and discuss its biological significance.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy

              Despite the success of immune checkpoint blockade against melanoma, many “cold” tumors like prostate cancer remain unresponsive. We found that hypoxic zones were prevalent across preclinical prostate cancer and resisted T cell infiltration even in the context of CTLA-4 and PD-1 blockade. We demonstrated that the hypoxia-activated prodrug TH-302 reduces or eliminates hypoxia in these tumors. Combination therapy with this hypoxia-prodrug and checkpoint blockade cooperated to cure more than 80% of tumors in the transgenic adenocarcinoma of the mouse prostate–derived (TRAMP-derived) TRAMP-C2 model. Immunofluorescence imaging showed that TH-302 drives an influx of T cells into hypoxic zones, which were expanded by checkpoint blockade. Further, combination therapy reduced myeloid-derived suppressor cell density by more than 50%, and durably reduced the capacity of the tumor to replenish the granulocytic subset. Spontaneous prostate tumors in TRAMP transgenic mice, which completely resist checkpoint blockade, showed minimal adenocarcinoma tumor burden at 36 weeks of age and no evidence of neuroendocrine tumors with combination therapy. Survival of Pb-Cre4 , Pten pc–/– Smad4 pc–/– mice with aggressive prostate adenocarcinoma was also significantly extended by this combination of hypoxia-prodrug and checkpoint blockade. Hypoxia disruption and T cell checkpoint blockade may sensitize some of the most therapeutically resistant cancers to immunotherapy.
                Bookmark

                Author and article information

                Journal
                Biomolecules
                Biomolecules
                biomolecules
                Biomolecules
                MDPI
                2218-273X
                12 February 2020
                February 2020
                : 10
                : 2
                : 282
                Affiliations
                [1 ]Environmental and Occupational Physiology Laboratory, Haute Ecole Bruxelles-Brabant, 1180 Brussels, Belgium; ftillmans@ 123456dan.org (F.T.); pgermonpre@ 123456gmail.com (P.G.);
                [2 ]Intensive Care Department, Brugmann University Hospital, 1020 Brussels, Belgium
                [3 ]Translational Research Laboratory, Université Libre de Bruxelles, 1050 Brussels, Belgium; francis.corazza@ 123456chu-brugmann.be
                [4 ]Clinic of Anesthesiology, Section Anaesthesiological Pathophysiology and Process Development, University of Ulm, 89081 Ulm, Germany; peter.radermacher@ 123456uni-ulm.de
                [5 ]Immunology Laboratory, Brugmann University Hospital, 1020 Brussels, Belgium
                [6 ]Experimental Medicine Llaboratory, La Sapienza University of Rome, 00185 Rome, Italy; mariano.bizzarri@ 123456uniroma1.it
                [7 ]Hyperbaric Centre, Queen Astrid Military Hospital, 1120 Brussels, Belgium
                [8 ]DAN Europe research (1160 Auderghem, Brussels, Belgium; 64026 Montepagano, Roseto, Italy)
                [9 ]Department of Computer Engineering, Galatasaray University; Ortakoy, 34349 Istanbul, Turkey; gunceorman@ 123456gmail.com
                [10 ]Motor Sciences Department, Physical Activity Tteaching Unit, Université Libre de Bruxelles (ULB), 1050 Brussels, Belgium
                Author notes
                [* ]Correspondence: david.debels@ 123456chu-brugmann.be ; Tel.: +3-224-779-293
                [†]

                These authors contributed equally to this paper.

                Author information
                https://orcid.org/0000-0002-2159-0834
                https://orcid.org/0000-0003-0408-4136
                https://orcid.org/0000-0003-0402-8417
                https://orcid.org/0000-0001-6771-839X
                Article
                biomolecules-10-00282
                10.3390/biom10020282
                7072400
                32059539
                9667a6ac-dfd6-4060-a496-7fb7b1a0fe67
                © 2020 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 29 December 2019
                : 11 February 2020
                Categories
                Article

                hyperoxia,leukemia,normobaric oxygen paradox,fractals,caspase,apoptosis

                Comments

                Comment on this article